Loading clinical trials...
Loading clinical trials...
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo Coronary Artery Bypass Surgery
Conditions
Interventions
Mesenchymal stem cell
Placebo
Start Date
September 1, 2025
Primary Completion Date
September 30, 2028
Completion Date
March 31, 2029
Last Updated
September 25, 2025
NCT05365282
NCT06863155
NCT06631157
NCT05788432
NCT05599061
NCT07373353
Lead Sponsor
Rohto Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions